Jakarta, (Antara) - Indonesia's eminent neurologist Dr Andreas Harry represented his country at the International Alzheimer Conference in London on July 16-20, 2017.
"This time, the conference is attended by thousands of neurologists and researchers in the field of Alzheimer's disease from 68 countries," Harry said when Antara here contacted him in London on Tuesday morning.
He remarked that the annual gathering, organized by the Alzheimer's Association International Conference, took place at the Excel London Convention Centre.
Harry said the most interesting topic discussed on the first day of the conference was "Passive Immunotherapy" with "beta amyloid" target, which is very "toxic."
"Active Immunotherapy" for individuals having the risk of Alzheimer Disease (AD) was also discussed on the first day of the conference.
AD is a progressive condition wherein the symptoms develop gradually and become more severe over the course of several years.
The first signs of AD are usually minor memory problems, such as failing to recall recent conversations or events and the names of places and objects.
As the condition develops, memory problems become more severe and further symptoms, such as confusion and disorientation, personality changes, hallucinations and delusions, and language and speech problems can develop.
There is no cure for the disease, which worsens as it progresses and eventually leads to death.
This progressive brain disorder was first described by German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after him.(*)
COPYRIGHT © ANTARA News Jawa Timur 2017
"This time, the conference is attended by thousands of neurologists and researchers in the field of Alzheimer's disease from 68 countries," Harry said when Antara here contacted him in London on Tuesday morning.
He remarked that the annual gathering, organized by the Alzheimer's Association International Conference, took place at the Excel London Convention Centre.
Harry said the most interesting topic discussed on the first day of the conference was "Passive Immunotherapy" with "beta amyloid" target, which is very "toxic."
"Active Immunotherapy" for individuals having the risk of Alzheimer Disease (AD) was also discussed on the first day of the conference.
AD is a progressive condition wherein the symptoms develop gradually and become more severe over the course of several years.
The first signs of AD are usually minor memory problems, such as failing to recall recent conversations or events and the names of places and objects.
As the condition develops, memory problems become more severe and further symptoms, such as confusion and disorientation, personality changes, hallucinations and delusions, and language and speech problems can develop.
There is no cure for the disease, which worsens as it progresses and eventually leads to death.
This progressive brain disorder was first described by German psychiatrist and neuropathologist Alois Alzheimer in 1906 and was named after him.(*)
Editor : Chandra Hamdani Noer
COPYRIGHT © ANTARA News Jawa Timur 2017